IBDEI0FL ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7505,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,7506,0)
 ;;=202.81^^49^558^61
 ;;^UTILITY(U,$J,358.3,7506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7506,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,7506,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,7506,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,7507,0)
 ;;=215.9^^49^558^85
 ;;^UTILITY(U,$J,358.3,7507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7507,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,7507,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,7507,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,7508,0)
 ;;=224.2^^49^558^51
 ;;^UTILITY(U,$J,358.3,7508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7508,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,7508,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,7508,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,7509,0)
 ;;=224.5^^49^558^96
 ;;^UTILITY(U,$J,358.3,7509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7509,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,7509,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,7509,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,7510,0)
 ;;=224.7^^49^558^28
 ;;^UTILITY(U,$J,358.3,7510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7510,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,7510,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,7510,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,7511,0)
 ;;=237.70^^49^558^66
 ;;^UTILITY(U,$J,358.3,7511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7511,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,7511,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,7511,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,7512,0)
 ;;=239.6^^49^558^65
 ;;^UTILITY(U,$J,358.3,7512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7512,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,7512,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,7512,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,7513,0)
 ;;=239.81^^49^558^97
 ;;^UTILITY(U,$J,358.3,7513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7513,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,7513,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,7513,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,7514,0)
 ;;=272.0^^49^558^48
 ;;^UTILITY(U,$J,358.3,7514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7514,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,7514,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,7514,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,7515,0)
 ;;=340.^^49^558^63
 ;;^UTILITY(U,$J,358.3,7515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7515,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,7515,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,7515,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,7516,0)
 ;;=345.90^^49^558^29
 ;;^UTILITY(U,$J,358.3,7516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7516,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,7516,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,7516,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,7517,0)
 ;;=368.02^^49^558^23
 ;;^UTILITY(U,$J,358.3,7517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7517,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,7517,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,7517,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,7518,0)
 ;;=368.11^^49^558^103
 ;;^UTILITY(U,$J,358.3,7518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7518,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,7518,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,7518,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,7519,0)
 ;;=368.59^^49^558^11
 ;;^UTILITY(U,$J,358.3,7519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7519,1,3,0)
 ;;=3^Color Blindness
